Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Snack selection influences glucose metabolism, antioxidant capacity and cholesterol in healthy overweight adults: A randomized parallel arm trial.

  • 2019-05
  • Nutrition research (New York, N.Y.) 65
    • Zachary S Clayton
    • Elizabeth Fusco
    • Lisa Schreiber
    • Jennifer N Carpenter
    • Shirin Hooshmand
    • Mee Young Hong
    • Mark Kern

Study Design

Type
Randomized Controlled Trial (RCT)
Population
overweight adults
Methods
8-weeks of twice-daily snacking of macronutrient-matched 100kcal servings of dried plums or refined carbohydrate-rich snack (low-fat muffins)
Blinding
Open-label
Duration
8 weeks
Funding
Unclear
Including carbohydrate/fructose-rich foods (predominantly fruit) in the diets of overweight individuals can improve chronic disease risk factors. We hypothesized dried plums (DP) would improve nutrient consumption, total antioxidant capacity (TAC), lipid and adipokine profiles, and would decrease adiposity and inflammation. To test this, we studied the effects of 8-weeks of twice-daily snacking of macronutrient-matched 100kcal servings of DP or refined carbohydrate-rich snack (low-fat muffins: LFM) on daily energy and nutrient consumption, and chronic disease risk factors in overweight adults. Body weight/composition, waist circumference, blood pressure, plasma glucose, insulin, c-peptide, lipids, TAC, adipokines and inflammation were measured at baseline and throughout the study. Postprandial glucose and insulin were assessed following assigned test foods at baseline and 8-weeks. Repeated measures ANOVAs were undertaken to examine group and time differences. Post-hoc independent and paired samples t-tests were conducted where necessary. DP increased (P<.05) overall intake of dietary fiber and potassium, and TAC, from baseline to 8-weeks. Baseline postprandial glycemia tended (P=.09) to be lower with DP versus LFM, while both groups had a decreased response after 8-weeks. Postprandial insulinemia was lower (P<.05) for DP at both time-points. No differences in body weight/composition, blood pressure, or fasting glucose, insulin, triglycerides, total cholesterol, HDL-C, inflammation or adipokines were detected. Low-density lipoprotein cholesterol (LDL-C) increased (P<.05) throughout the trial following LFM. Overall, DP lessened postprandial insulinemia, improved nutrient consumption and plasma TAC, and maintained plasma LDL-C compared to a macronutrient-matched refined carbohydrate snack, which could decrease chronic disease risk.

Research Insights

  • Postprandial insulinemia was lower (P<.05) for DP at both time-points

    Effect
    Beneficial
    Effect size
    Small
    Dose
    100 kcal servings twice-daily
  • No differences in body weight/composition, blood pressure, or fasting glucose, insulin, triglycerides, total cholesterol, HDL-C, inflammation or adipokines were detected

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 kcal servings twice-daily
  • DP increased (P<.05) overall intake of dietary fiber and potassium, and TAC

    Effect
    Beneficial
    Effect size
    Small
    Dose
    100 kcal servings twice-daily
  • No differences in body weight/composition, blood pressure, or fasting glucose, insulin, triglycerides, total cholesterol, HDL-C, inflammation or adipokines were detected

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 kcal servings twice-daily
  • DP increased (P<.05) overall intake of dietary fiber and potassium, and TAC

    Effect
    Beneficial
    Effect size
    Small
    Dose
    100 kcal servings twice-daily
  • DP increased (P<.05) overall intake of dietary fiber and potassium, and TAC

    Effect
    Beneficial
    Effect size
    Small
    Dose
    100 kcal servings twice-daily
  • No differences in body weight/composition, blood pressure, or fasting glucose, insulin, triglycerides, total cholesterol, HDL-C, inflammation or adipokines were detected.

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 kcal servings twice daily
  • No differences in body weight/composition, blood pressure, or fasting glucose, insulin, triglycerides, total cholesterol, HDL-C, inflammation or adipokines were detected

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 kcal servings twice-daily
  • No differences in body weight/composition, blood pressure, or fasting glucose, insulin, triglycerides, total cholesterol, HDL-C, inflammation or adipokines were detected

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 kcal servings twice-daily
  • No differences in body weight/composition, blood pressure, or fasting glucose, insulin, triglycerides, total cholesterol, HDL-C, inflammation or adipokines were detected

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 kcal servings twice-daily
  • No differences in body weight/composition, blood pressure, or fasting glucose, insulin, triglycerides, total cholesterol, HDL-C, inflammation or adipokines were detected

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 kcal servings twice-daily
  • No differences in body weight/composition, blood pressure, or fasting glucose, insulin, triglycerides, total cholesterol, HDL-C, inflammation or adipokines were detected.

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 kcal servings twice daily
  • No differences in body weight/composition, blood pressure, or fasting glucose, insulin, triglycerides, total cholesterol, HDL-C, inflammation or adipokines were detected

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 kcal servings twice-daily
  • No differences in body weight/composition, blood pressure, or fasting glucose, insulin, triglycerides, total cholesterol, HDL-C, inflammation or adipokines were detected

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 kcal servings twice-daily
  • No differences in body weight/composition, blood pressure, or fasting glucose, insulin, triglycerides, total cholesterol, HDL-C, inflammation or adipokines were detected

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 kcal servings twice-daily
  • Low-density lipoprotein cholesterol (LDL-C) increased (P<.05) throughout the trial following LFM

    Effect
    Beneficial
    Effect size
    Small
    Dose
    100 kcal servings twice-daily
  • Low-density lipoprotein cholesterol (LDL-C) increased (P<.05) throughout the trial following LFM.

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 kcal servings twice daily
  • Baseline postprandial glycemia tended (P=.09) to be lower with DP versus LFM

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 kcal servings twice-daily
  • No differences in body weight/composition, blood pressure, or fasting glucose, insulin, triglycerides, total cholesterol, HDL-C, inflammation or adipokines were detected.

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 kcal servings twice daily
  • No differences in body weight/composition, blood pressure, or fasting glucose, insulin, triglycerides, total cholesterol, HDL-C, inflammation or adipokines were detected

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 kcal servings twice-daily
  • No differences in body weight/composition, blood pressure, or fasting glucose, insulin, triglycerides, total cholesterol, HDL-C, inflammation or adipokines were detected

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 kcal servings twice-daily
Back to top